Weil Company, Inc. - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 15 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Weil Company, Inc. ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q4 2021$347,000
-16.4%
21,210
-13.6%
0.16%
-25.0%
Q3 2021$415,000
-35.8%
24,558
-19.4%
0.22%
-33.7%
Q2 2021$646,00030,4680.33%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q2 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$4,056,9219.19%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 463,899$3,256,5710.62%
VILLERE ST DENIS J & CO LLC 289,797$2,034,3740.15%
BENJAMIN F. EDWARDS & COMPANY, INC. 65,911$4630.02%
Shay Capital LLC 10,000$70,2000.01%
SIMON QUICK ADVISORS, LLC 13,202$92,6780.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,120$162,3020.00%
BROWN ADVISORY INC 73,849$518,4200.00%
Geneos Wealth Management Inc. 750$5,2650.00%
Focused Wealth Management, Inc 242$1,6990.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders